• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Venus Remedies Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4791.0
  • ISIN : INE411B01019
435.20 30 (7.36%)
  • As on 31 May 2025 (EOD)

  • Today’s Low

    405.60

  • Today’s High

    439.50

  • Open

    409.00

  • Perv Close

    405.35

  • 52W Low

    270.25

  • 52W High

    439.50

Key Indicators

  • P/E(TTM)

    12.70

  • Mar.Cap (₹Cr.)

    581.73

  • Div & Yield %

    0.00

  • Book Value(₹)

    441.01

  • Debt-Equity Ratio

    7.36

  • AGM Date

    30-May-2025

  • EPS

    34.39

  • P/E Ratio

    12.70

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    581.73

  • RONW (%)

    6.01

  • ROCE (%)

    8.52

Score Board

  • Equity (₹ in Cr.)

    13.37

  • BV (₹)

    441.00

  • Sales( ₹ in Cr.)

    639.46

  • NP (in Cr.)

    45.96

  • NP Var(%)

    53.0

  • Div%

    0.0

  • CPS (₹)

    50.60

  • EPS (₹)

    34.40

  • Traded Value (₹ in Lakhs)

    583.87

  • 52 Week High

    439.50

  • 52 Week Low

    270.25

  • Price BSE

    437.0

  • Price NSE

    435.00

  • Market Capital( in Cr.)

    583.87

  • P/C Ratio

    8.60

  • P/E Ratio

    12.70

  • Price Vs.BV

    34.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 575.21 537.66 576.71 514.62 320.23 301.84
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 575.21 537.66 576.71 514.62 320.23 301.84
Other Income 11.32 10.17 8.43 50.37 34.93 4.51
Stock Adjustments 5.00 -14.26 -3.19 7.36 -6.21 7.98
Total Income 591.53 533.57 581.95 572.35 348.95 314.33
EXPENDITURE :            
Raw Materials 357.22 322.44 374.31 344.04 170.60 189.76
Power and Fuel Cost 4.99 4.17 3.78 3.39 3.41 3.50
Employee Cost 57.57 47.67 43.75 35.89 33.79 30.26
Other Manufacturing Expenses 10.07 6.18 6.47 4.51 3.63 3.90
Selling and Administration Expenses 89.17 81.16 76.40 87.29 59.53 48.10
Miscellaneous Expenses 0.31 0.26 0.00 9.17 40.16 8.96
Employee Benefit Expenses 57.57 47.67 43.75 35.89 33.79 30.26
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 519.33 461.88 504.71 484.28 311.12 284.49
Operating Profit 72.21 71.70 77.25 88.07 37.84 29.84
Interest 0.00 0.00 0.00 12.73 13.05 25.15
Gross Profit 72.21 71.70 77.25 75.34 24.79 4.69
Depreciation 25.55 31.37 32.58 34.28 31.05 32.95
Profit Before Tax 46.66 40.33 44.67 41.06 -6.26 -28.26
Current Tax 12.22 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.93 11.36 -4.32 -13.21 1.96 -1.15
Reported Net Profit 30.50 28.96 48.99 54.27 -8.23 -27.11
Extraordinary Items 0.37 0.01 0.00 23.44 -6.85 -8.96
Adjusted Net Profit 30.13 28.95 48.99 30.83 -1.38 -18.15
Adjustment below Net Profit -0.19 -0.46 0.24 -0.10 -0.47 0.07
P & L Balance brought forward 164.76 136.26 87.02 32.85 41.55 68.59
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 195.07 164.76 136.26 87.02 32.85 41.55
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 22.82 21.67 36.65 43.97 -6.67 -21.97
Earnings Per Share(Adj)-Unit Curr 22.82 21.67 36.65 43.97 -6.67 -21.97
Book Value 380.48 357.63 336.21 313.10 269.21 276.25
Book Value(Adj)-Unit Curr 380.48 357.63 336.21 313.10 269.21 276.25

Shareholding Pattern

  • Promoter Group

    41.76%

  • Public Share Holding

    58.24%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,300,000 17.21 2,300,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,281,997 24.55 3,281,997 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,581,997 41.76 5,581,997 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 179,032 1.34 179,032 5
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 179,032 1.34 179,032 5
2] Non Institution
Bodies Corporate 256,729 1.92 256,429 108
Clearing Members 1,100 0.01 1,100 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 605,587 4.53 605,587 354
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 321,327 2.40 321,327 518
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,498,323 11.21 1,498,323 24
Individuals holding nominal share capital up to Rs. 1 lakh 4,758,848 35.60 4,652,387 18,950
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 134,141 1.00 134,141 1
Sub Total 7,605,959 56.90 7,499,198 19,972
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 13,366,988 100.00 13,260,227 19,982

Company Background

Venus Remedies LtdPharmaceuticals - Indian - Formulations

  • Venus Remedies Ltd
  • BSE Code : 4791.0
  • ISIN : INE411B01019

  • Incorporation Year

    1989

  • Registered Office

    S C No 857 Cabin No 10 2nd Flr
    N A C Manimajra, Chandigarh,
    Chandigarh-160101

  • Telephone

  • FAX

  • Chairman

    Pawan Chaudhary

  • Managing Director

    Pawan Chaudhary

  • Company Secretary

    Neha Kodan

  • Auditor

    J K Jain & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    Narang Tower,
    44 Community Centre,Naraina Ind Area
    Mumbai - New Delhi-110028

Venus Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Venus Remedies 436.80 586.53 575.21 11.11 8.61
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92